Metastatic Non-Small Cell Lung Cancer

Also known as: Metastatic Non-small Cell Lung Cancers / Metastatic Nonsmall Cell Lung Cancer / Metastatic NSCLC / Metastatic Non-Small Cell Lung Carcinoma / Metastatic Non-small Cell Lung Cancer (NSCLC) / Non-small cell lung cancer metastatic / Metastatic non-small cell lung cancer (disorder) / Lung cancer non-small cell stage IV / Non-small cell lung cancer stage IV

DrugDrug NameDrug Description
DB15568AdagrasibA KRAS inhibitor indicated for the treatment of locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy.
DB08916AfatinibAn antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy.
DB16695AmivantamabAn EGF and MET receptor targeted antibody indicated in the treatment of non-small cell lung cancer with an EGFR 20 exon insertion mutation.
DB11595AtezolizumabA monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy.
DB11967BinimetinibA medication used to treat metastatic melanoma with specific mutations.
DB12267BrigatinibAn anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
DB11791CapmatinibA kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping.
DB14707CemiplimabA programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer.
DB08865CrizotinibA receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.
DB08912DabrafenibA kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
DB11963DacomitinibA medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution.
DB11714DurvalumabAn antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer.
DB11718EncorafenibA kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations.
DB11986EntrectinibEntrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment...
DB00530ErlotinibAn EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers.
DB00317GefitinibA tyrosine kinase inhibitor used as first-line therapy to treat non-small cell lung carcinoma (NSCLC) that meets certain genetic mutation criteria.
DB06186IpilimumabA human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.
DB12130LorlatinibAn anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
DB16390MobocertinibAn oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.
DB09559NecitumumabA monoclonal antibody used to treat metastatic squamous non-small cell lung cancer.
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09330OsimertinibA tyrosine kinase inhibitor used in the treatment of certain types of non-small cell lung carcinoma.
DB01229PaclitaxelA taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DB05578RamucirumabAn antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply.
DB15569SotorasibAn experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer.
DB15133TepotinibAn oral tyrosine kinase inhibitor targeted against MET for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.
DB08911TrametinibA kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer.
DB11771TremelimumabAn anti-CTLA-4 antibody used to treat unresectable hepatocellular carcinoma in combination with durvalumab.
DB00361VinorelbineA vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC.
DrugDrug NameTargetType
DB15568AdagrasibGTPase KRastarget
DB15568AdagrasibCytochrome P450 3A4enzyme
DB15568AdagrasibCytochrome P450 2C8enzyme
DB15568AdagrasibCytochrome P450 1A2enzyme
DB15568AdagrasibCytochrome P450 2B6enzyme
DB15568AdagrasibCytochrome P450 2C9enzyme
DB15568AdagrasibCytochrome P450 2D6enzyme
DB15568AdagrasibP-glycoprotein 1transporter
DB08916AfatinibEpidermal growth factor receptortarget
DB08916AfatinibReceptor tyrosine-protein kinase erbB-2target
DB08916AfatinibReceptor tyrosine-protein kinase erbB-4target
DB08916AfatinibP-glycoprotein 1transporter
DB08916AfatinibATP-binding cassette sub-family G member 2transporter
DB16695AmivantamabEpidermal growth factor receptortarget
DB16695AmivantamabHepatocyte growth factor receptortarget
DB16695AmivantamabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB11595AtezolizumabProgrammed cell death 1 ligand 1target
DB11595AtezolizumabProgrammed cell death protein 1target
DB11967BinimetinibUDP-glucuronosyltransferase 1-1enzyme
DB11967BinimetinibCytochrome P450 1A2enzyme
DB11967BinimetinibCytochrome P450 2C19enzyme
DB11967BinimetinibDual specificity mitogen-activated protein kinase kinase 2target
DB11967BinimetinibSerum albumincarrier
DB11967BinimetinibDual specificity mitogen-activated protein kinase kinase 1target
DB11967BinimetinibATP-binding cassette sub-family G member 2transporter
DB11967BinimetinibP-glycoprotein 1transporter
DB12267BrigatinibALK tyrosine kinase receptortarget
DB12267BrigatinibEpidermal growth factor receptortarget
DB12267BrigatinibTyrosine-protein kinase ABL1target
DB12267BrigatinibInsulin-like growth factor 1 receptortarget
DB12267BrigatinibReceptor-type tyrosine-protein kinase FLT3target
DB12267BrigatinibCytochrome P450 2C8enzyme
DB12267BrigatinibCytochrome P450 3A4enzyme
DB12267BrigatinibInsulin receptortarget
DB12267BrigatinibHepatocyte growth factor receptortarget
DB12267BrigatinibReceptor tyrosine-protein kinase erbB-4target
DB12267BrigatinibReceptor tyrosine-protein kinase erbB-2target
DB12267BrigatinibATP-binding cassette sub-family B member 5transporter
DB12267BrigatinibATP-binding cassette sub-family G member 2transporter
DB12267BrigatinibSolute carrier family 22 member 1transporter
DB12267BrigatinibMultidrug and toxin extrusion protein 1transporter
DB12267BrigatinibMultidrug and toxin extrusion protein 2transporter
DB12267BrigatinibCytochrome P450 3A Subfamilyenzyme
DB11791CapmatinibCytochrome P450 3A4enzyme
DB11791CapmatinibAldehyde oxidaseenzyme
DB11791CapmatinibHepatocyte growth factor receptortarget
DB11791CapmatinibP-glycoprotein 1transporter
DB11791CapmatinibMultidrug and toxin extrusion protein 1transporter
DB11791CapmatinibMultidrug and toxin extrusion protein 2transporter
DB11791CapmatinibCytochrome P450 1A2enzyme
DB11791CapmatinibATP-binding cassette sub-family G member 2transporter
DB14707CemiplimabProgrammed cell death protein 1target
DB08865CrizotinibCytochrome P450 3A4enzyme
DB08865CrizotinibCytochrome P450 3A5enzyme
DB08865CrizotinibP-glycoprotein 1transporter
DB08865CrizotinibALK tyrosine kinase receptortarget
DB08865CrizotinibHepatocyte growth factor receptortarget
DB08865CrizotinibCytochrome P450 2B6enzyme
DB08865CrizotinibCytochrome P450 3A Subfamilyenzyme
DB08865CrizotinibSerum albumincarrier
DB08865Crizotinibalpha1-acid glycoproteincarrier
DB08865CrizotinibProto-oncogene tyrosine-protein kinase ROStarget
DB08865CrizotinibMacrophage-stimulating protein receptortarget
DB08912DabrafenibCytochrome P450 3A4enzyme
DB08912DabrafenibCytochrome P450 2C8enzyme
DB08912DabrafenibP-glycoprotein 1transporter
DB08912DabrafenibATP-binding cassette sub-family G member 2transporter
DB08912DabrafenibSolute carrier organic anion transporter family member 1B1transporter
DB08912DabrafenibSolute carrier organic anion transporter family member 1B3transporter
DB08912DabrafenibSolute carrier family 22 member 6transporter
DB08912DabrafenibSolute carrier family 22 member 8transporter
DB08912DabrafenibSerine/threonine-protein kinase B-raftarget
DB08912DabrafenibRAF proto-oncogene serine/threonine-protein kinasetarget
DB08912DabrafenibSerine/threonine-protein kinase SIK1target
DB08912DabrafenibSerine/threonine-protein kinase Nek11target
DB08912DabrafenibLIM domain kinase 1target
DB08912DabrafenibCytochrome P450 2B6enzyme
DB08912DabrafenibCytochrome P450 2C9enzyme
DB08912DabrafenibCytochrome P450 2C19enzyme
DB08912DabrafenibCytochrome P450 1A2enzyme
DB08912DabrafenibSerum albumincarrier
DB08912DabrafenibSolute carrier organic anion transporter family member 1A2transporter
DB08912DabrafenibSolute carrier family 22 member 2transporter
DB08912DabrafenibUDP-glucuronosyltransferase 1-1enzyme
DB11963DacomitinibCytochrome P450 2D6enzyme
DB11963DacomitinibSerum albumincarrier
DB11963DacomitinibCytochrome P450 3A4enzyme
DB11963DacomitinibCytochrome P450 2C9enzyme
DB11963DacomitinibUDP-glucuronosyltransferase 1-1enzyme
DB11963DacomitinibP-glycoprotein 1transporter
DB11963DacomitinibATP-binding cassette sub-family G member 2transporter
DB11963DacomitinibSolute carrier family 22 member 1transporter
DB11963DacomitinibEpidermal growth factor receptortarget
DB11714DurvalumabProgrammed cell death 1 ligand 1target
DB11714DurvalumabProgrammed cell death protein 1target
DB11718EncorafenibCytochrome P450 3A4enzyme
DB11718EncorafenibCytochrome P450 2C19enzyme
DB11718EncorafenibCytochrome P450 2D6enzyme
DB11718EncorafenibSerine/threonine-protein kinase B-raftarget
DB11718EncorafenibG1/S-specific cyclin-D1target
DB11718EncorafenibUDP-glucuronosyltransferase 1-1enzyme
DB11718EncorafenibSerum albumincarrier
DB11718EncorafenibCytochrome P450 1A2enzyme
DB11718EncorafenibCytochrome P450 2B6enzyme
DB11718EncorafenibCytochrome P450 2C8enzyme
DB11718EncorafenibCytochrome P450 2C9enzyme
DB11718EncorafenibCytochrome P450 3A5enzyme
DB11718EncorafenibCytochrome P450 3A7enzyme
DB11718EncorafenibP-glycoprotein 1transporter
DB11718EncorafenibSolute carrier family 22 member 2transporter
DB11718EncorafenibATP-binding cassette sub-family G member 2transporter
DB11718EncorafenibSolute carrier family 22 member 6transporter
DB11718EncorafenibSolute carrier family 22 member 8transporter
DB11718EncorafenibSolute carrier organic anion transporter family member 1B1transporter
DB11718EncorafenibSolute carrier organic anion transporter family member 1B3transporter
DB11718EncorafenibRAF proto-oncogene serine/threonine-protein kinasetarget
DB11718EncorafenibMitogen-activated protein kinase 8target
DB11718EncorafenibMitogen-activated protein kinase 9target
DB11718EncorafenibMitogen-activated protein kinase 10target
DB11718EncorafenibLIM domain kinase 1target
DB11718EncorafenibLIM domain kinase 2target
DB11718EncorafenibDual specificity mitogen-activated protein kinase kinase 4target
DB11718EncorafenibSerine/threonine-protein kinase 36target
DB11986EntrectinibCytochrome P450 3A4enzyme
DB11986EntrectinibP-glycoprotein 1transporter
DB11986EntrectinibHigh affinity nerve growth factor receptortarget
DB11986EntrectinibBDNF/NT-3 growth factors receptortarget
DB11986EntrectinibNT-3 growth factor receptortarget
DB11986EntrectinibProto-oncogene tyrosine-protein kinase ROStarget
DB11986EntrectinibTyrosine-protein kinase JAK2target
DB11986EntrectinibActivated CDC42 kinase 1target
DB00530ErlotinibEpidermal growth factor receptortarget
DB00530ErlotinibCytochrome P450 3A4enzyme
DB00530ErlotinibATP-binding cassette sub-family G member 2transporter
DB00530ErlotinibP-glycoprotein 1transporter
DB00530ErlotinibNuclear receptor subfamily 1 group I member 2target
DB00530ErlotinibCytochrome P450 3A5enzyme
DB00530ErlotinibCytochrome P450 1A1enzyme
DB00530ErlotinibCytochrome P450 1A2enzyme
DB00530ErlotinibCytochrome P450 1B1enzyme
DB00530ErlotinibCytochrome P450 2D6enzyme
DB00530ErlotinibCytochrome P450 2C8enzyme
DB00530ErlotinibUDP-glucuronosyltransferase 1-1enzyme
DB00530ErlotinibSerum albumincarrier
DB00530ErlotinibAlpha-1-acid glycoprotein 1carrier
DB00530ErlotinibSolute carrier organic anion transporter family member 2B1transporter
DB00530ErlotinibEpidermal growth factor receptorenzyme
DB00317GefitinibEpidermal growth factor receptortarget
DB00317GefitinibCytochrome P450 3A4enzyme
DB00317GefitinibCytochrome P450 2D6enzyme
DB00317GefitinibP-glycoprotein 1transporter
DB00317GefitinibATP-binding cassette sub-family G member 2transporter
DB00317GefitinibCytochrome P450 3A5enzyme
DB00317GefitinibCytochrome P450 1A1enzyme
DB00317GefitinibCytochrome P450 2C9enzyme
DB00317GefitinibCytochrome P450 2C19enzyme
DB00317GefitinibSerum albumincarrier
DB00317GefitinibAlpha-1-acid glycoprotein 1carrier
DB06186IpilimumabCytotoxic T-lymphocyte protein 4target
DB12130LorlatinibALK tyrosine kinase receptortarget
DB12130LorlatinibCytochrome P450 3A Subfamilyenzyme
DB12130LorlatinibCytochrome P450 3A5enzyme
DB12130LorlatinibCytochrome P450 2B6enzyme
DB12130LorlatinibCytochrome P450 2C8enzyme
DB12130LorlatinibCytochrome P450 2C19enzyme
DB12130LorlatinibUDP-glucuronosyltransferase 1-3enzyme
DB12130LorlatinibCytochrome P450 3A4enzyme
DB16390MobocertinibEpidermal growth factor receptortarget
DB16390MobocertinibCytochrome P450 3A4enzyme
DB16390MobocertinibCytochrome P450 3A5enzyme
DB16390MobocertinibCytochrome P450 3A7enzyme
DB16390MobocertinibP-glycoprotein 1transporter
DB16390MobocertinibATP-binding cassette sub-family G member 2transporter
DB09559NecitumumabEpidermal growth factor receptortarget
DB09035NivolumabProgrammed cell death protein 1target
DB09035NivolumabProgrammed cell death 1 ligand 1target
DB09330OsimertinibEpidermal growth factor receptortarget
DB09330OsimertinibP-glycoprotein 1transporter
DB09330OsimertinibATP-binding cassette sub-family G member 2transporter
DB09330OsimertinibCytochrome P450 3A4enzyme
DB09330OsimertinibCytochrome P450 1A2enzyme
DB01229PaclitaxelApoptosis regulator Bcl-2target
DB01229PaclitaxelTubulin beta-1 chaintarget
DB01229PaclitaxelCytochrome P450 2C8enzyme
DB01229PaclitaxelCytochrome P450 3A4enzyme
DB01229PaclitaxelCytochrome P450 3A5enzyme
DB01229PaclitaxelCytochrome P450 3A7enzyme
DB01229PaclitaxelBile salt export pumptransporter
DB01229PaclitaxelP-glycoprotein 1transporter
DB01229PaclitaxelMultidrug resistance-associated protein 1transporter
DB01229PaclitaxelMultidrug resistance-associated protein 7transporter
DB01229PaclitaxelCytochrome P450 19A1enzyme
DB01229PaclitaxelCytochrome P450 1B1enzyme
DB01229PaclitaxelSolute carrier organic anion transporter family member 1B3transporter
DB01229PaclitaxelNuclear receptor subfamily 1 group I member 2target
DB01229PaclitaxelMicrotubule-associated protein 4target
DB01229PaclitaxelMicrotubule-associated protein 2target
DB01229PaclitaxelMicrotubule-associated protein tautarget
DB01229PaclitaxelCanalicular multispecific organic anion transporter 1transporter
DB09037PembrolizumabProgrammed cell death protein 1target
DB09037PembrolizumabProgrammed cell death 1 ligand 1target
DB05578RamucirumabVascular endothelial growth factor receptor 2target
DB15569SotorasibGTPase KRastarget
DB15569SotorasibCytochrome P450 3A Subfamilyenzyme
DB15569SotorasibCytochrome P450 2C8enzyme
DB15569SotorasibCytochrome P450 2C9enzyme
DB15569SotorasibCytochrome P450 2B6enzyme
DB15569SotorasibATP-binding cassette sub-family G member 2transporter
DB15569SotorasibP-glycoprotein 1transporter
DB15133TepotinibP-glycoprotein 1transporter
DB15133TepotinibCytochrome P450 3A4enzyme
DB15133TepotinibCytochrome P450 2C8enzyme
DB15133TepotinibATP-binding cassette sub-family G member 2transporter
DB15133TepotinibHepatocyte growth factor receptortarget
DB15133TepotinibNischarintarget
DB15133TepotinibMelatonin receptor type 1Btarget
DB15133TepotinibSerum albumincarrier
DB15133TepotinibAlpha-1-acid glycoprotein 1carrier
DB15133TepotinibSolute carrier family 22 member 1transporter
DB15133TepotinibSolute carrier family 22 member 2transporter
DB15133TepotinibMultidrug and toxin extrusion protein 1transporter
DB15133TepotinibMultidrug and toxin extrusion protein 2transporter
DB15133TepotinibBile salt export pumptransporter
DB15133TepotinibCytochrome P450 2C9enzyme
DB08911TrametinibCytochrome P450 2C8enzyme
DB08911TrametinibCytochrome P450 3A4enzyme
DB08911TrametinibDual specificity mitogen-activated protein kinase kinase 1target
DB08911TrametinibDual specificity mitogen-activated protein kinase kinase 2target
DB11771TremelimumabCytotoxic T-lymphocyte protein 4target
DB00361VinorelbineTubulin beta chaintarget
DB00361VinorelbineCytochrome P450 3A4enzyme
DB00361VinorelbineCytochrome P450 2D6enzyme
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin0Completed1
DB11945Avelumab0Completed1
DB09035Nivolumab0Completed1
DB09037Pembrolizumab0Completed1
DB12001Abemaciclib1Completed1
DB17146Abequolixron1Recruiting1
DB00640Adenosine1Suspended1
DB00041Aldesleukin1Completed1
DB16087Alflutinib1Recruiting1
DB16640Almonertinib1Recruiting1
DB11595Atezolizumab1Not Yet Recruiting1
DB11595Atezolizumab1Recruiting3
DB09495Avobenzone1Recruiting1
DB06769Bendamustine1Recruiting1
DB11794Berzosertib1Active Not Recruiting1
DB00112Bevacizumab1Active Not Recruiting2
DB00112Bevacizumab1Completed1
DB00112Bevacizumab1Recruiting1
DB12267Brigatinib1Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB01373Calcium1Active Not Recruiting1
DB04690Camptothecin1Active Not Recruiting1
DB01101Capecitabine1Active Not Recruiting1
DB11791Capmatinib1Recruiting1
DB00958Carboplatin1Active Not Recruiting5
DB00958Carboplatin1Recruiting1
DB08889Carfilzomib1Not Yet Recruiting1
DB09063Ceritinib1Active Not Recruiting1
DB00002Cetuximab1Completed1
DB00002Cetuximab1Not Yet Recruiting1
DB00515Cisplatin1Active Not Recruiting1
DB16372Cobolimab1Active Not Recruiting1
DB00531Cyclophosphamide1Active Not Recruiting1
DB00531Cyclophosphamide1Completed2
DB00531Cyclophosphamide1Recruiting3
DB11963Dacomitinib1Active Not Recruiting1
DB14825Danvatirsen1Active Not Recruiting1
DB00694Daunorubicin1Active Not Recruiting1
DB01248Docetaxel1Active Not Recruiting1
DB01248Docetaxel1Recruiting1
DB15627Dostarlimab1Active Not Recruiting1
DB00997Doxorubicin1Active Not Recruiting1
DB11714Durvalumab1Active Not Recruiting1
DB11718Encorafenib1Completed1
DB14860Ensartinib1Active Not Recruiting1
DB14860Ensartinib1Completed1
DB08871Eribulin1Active Not Recruiting1
DB01175Escitalopram1Active Not Recruiting1
DB17506Etrumadenant1Active Not Recruiting1
DB01073Fludarabine1Completed1
DB01073Fludarabine1Recruiting2
DB00544Fluorouracil1Active Not Recruiting1
DB11679Fruquintinib1Recruiting1
DB00441Gemcitabine1Active Not Recruiting1
DB00441Gemcitabine1Completed1
DB00441Gemcitabine1Terminated1
DB16417Geptanolimab1Recruiting1
DB17508Hafnium oxide1Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB06186Ipilimumab1Recruiting1
DB00762Irinotecan1Active Not Recruiting1
DB00650Leucovorin1Active Not Recruiting1
DB11596Levoleucovorin1Active Not Recruiting1
DB13982Lutetium Lu-1771Recruiting1
DB05477MUC1 Dendritic Cell Vaccine1Active Not Recruiting1
DB00683Midazolam1Completed1
DB09559Necitumumab1Active Not Recruiting1
DB11793Niraparib1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting4
DB09035Nivolumab1Completed1
DB09035Nivolumab1Recruiting1
DB09035Nivolumab1Suspended1
DB09496Octinoxate1Recruiting1
DB09074Olaparib1Active Not Recruiting1
DB15088Oleclumab1Active Not Recruiting1
DB09330Osimertinib1Active Not Recruiting3
DB09330Osimertinib1Not Yet Recruiting1
DB09330Osimertinib1Recruiting2
DB00526Oxaliplatin1Active Not Recruiting1
DB01229Paclitaxel1Active Not Recruiting3
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Terminated1
DB06589Pazopanib1Terminated1
DB09037Pembrolizumab1Active Not Recruiting3
DB09037Pembrolizumab1Recruiting5
DB09037Pembrolizumab1Terminated3
DB00642Pemetrexed1Active Not Recruiting5
DB00642Pemetrexed1Recruiting1
DB05992Plinabulin1Active Not Recruiting1
DB11836Sapanisertib1Active Not Recruiting1
DB11836Sapanisertib1Suspended1
DB00020Sargramostim1Recruiting1
DB11942Selinexor1Active Not Recruiting1
DB09143Sonidegib1Recruiting1
DB15569Sotorasib1Not Yet Recruiting1
DB15569Sotorasib1Recruiting2
DB17109Tegavivint1Recruiting1
DB15232Telaglenastat1Suspended1
DB16409Tiragolumab1Recruiting1
DB01030Topotecan1Active Not Recruiting1
DB08911Trametinib1Recruiting1
DB00755Tretinoin1Recruiting1
DB11652Tucatinib1Not Yet Recruiting1
DB00135Tyrosine1Active Not Recruiting1
DB00361Vinorelbine1Terminated1
DB17170WSD-09221Recruiting1
DB13104X-3961Active Not Recruiting1
DB13104X-3961Completed1
DB17505Zimberelimab1Active Not Recruiting1
DB15327Abivertinib1 / 2Active Not Recruiting1
DB00041Aldesleukin1 / 2Not Yet Recruiting1
DB05220Alisertib1 / 2Terminated1
DB11595Atezolizumab1 / 2Terminated2
DB11945Avelumab1 / 2Terminated1
DB06626Axitinib1 / 2Terminated1
DB15387Bintrafusp alfa1 / 2Completed1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Not Yet Recruiting1
DB00531Cyclophosphamide1 / 2Terminated1
DB12159Dupilumab1 / 2Recruiting1
DB11714Durvalumab1 / 2Completed1
DB16091EMB-011 / 2Not Yet Recruiting1
DB00530Erlotinib1 / 2Terminated1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Not Yet Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB17367Gavocabtagene autoleucel1 / 2Active Not Recruiting1
DB17475Incomplete Freund's adjuvant1 / 2Recruiting1
DB06186Ipilimumab1 / 2Active Not Recruiting2
DB06186Ipilimumab1 / 2Terminated1
DB09559Necitumumab1 / 2Recruiting1
DB14145Nepidermin1 / 2Recruiting1
DB09079Nintedanib1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Active Not Recruiting2
DB09035Nivolumab1 / 2Completed1
DB06132Nivolumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting3
DB09035Nivolumab1 / 2Terminated1
DB09567Olive oil1 / 2Recruiting1
DB09330Osimertinib1 / 2Not Yet Recruiting1
DB09330Osimertinib1 / 2Recruiting4
DB09073Palbociclib1 / 2Terminated1
DB09037Pembrolizumab1 / 2Active Not Recruiting2
DB09037Pembrolizumab1 / 2Not Yet Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB14904Pimasertib1 / 2Completed1
DB17536Sirpiglenastat1 / 2Terminated1
DB16413Sotigalimab1 / 2Completed1
DB15232Telaglenastat1 / 2Recruiting1
DB08911Trametinib1 / 2Active Not Recruiting1
DB00072Trastuzumab1 / 2Recruiting1
DB11771Tremelimumab1 / 2Completed1
DB17509UCPVax1 / 2Active Not Recruiting1
DB15310Vactosertib1 / 2Active Not Recruiting1
DB16823Vebreltinib1 / 2Recruiting1
DB18442ABSK-0912Completed1
DB15327Abivertinib2Unknown Status1
DB00062Albumin human2Not Yet Recruiting1
DB00062Albumin human2Recruiting1
DB11363Alectinib2Terminated1
DB16640Almonertinib2Unknown Status1
DB16695Amivantamab2Active Not Recruiting1
DB16695Amivantamab2Recruiting1
DB11885Anlotinib2Recruiting1
DB11595Atezolizumab2Active Not Recruiting1
DB11595Atezolizumab2Recruiting1
DB11595Atezolizumab2Withdrawn1
DB00112Bevacizumab2Active Not Recruiting2
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Recruiting1
DB00112Bevacizumab2Unknown Status1
DB06772Cabazitaxel2Completed1
DB14776Camrelizumab2Recruiting1
DB12218Capivasertib2Completed1
DB00958Carboplatin2Active Not Recruiting3
DB00958Carboplatin2Completed1
DB00958Carboplatin2Not Yet Recruiting1
DB00958Carboplatin2Recruiting5
DB04849Cediranib2Active Not Recruiting1
DB14707Cemiplimab2Not Yet Recruiting1
DB00515Cisplatin2Active Not Recruiting1
DB00515Cisplatin2Completed1
DB00515Cisplatin2Recruiting2
DB00515Cisplatin2Suspended1
DB00515Cisplatin2Terminated1
DB00515Cisplatin2Unknown Status1
DB05239Cobimetinib2Active Not Recruiting1
DB01914D-glucose2Terminated1
DB11963Dacomitinib2Recruiting1
DB01248Docetaxel2Active Not Recruiting1
DB01248Docetaxel2Completed3
DB01248Docetaxel2Recruiting3
DB01248Docetaxel2Suspended1
DB01248Docetaxel2Terminated1
DB01248Docetaxel2Unknown Status1
DB11714Durvalumab2Active Not Recruiting1
DB11714Durvalumab2Completed1
DB11714Durvalumab2Recruiting1
DB00530Erlotinib2Completed2
DB14951Etirinotecan pegol2Completed1
DB00544Fluorouracil2Completed1
DB00441Gemcitabine2Completed2
DB00441Gemcitabine2Terminated1
DB06186Ipilimumab2Active Not Recruiting1
DB00762Irinotecan2Completed1
DB01167Itraconazole2Terminated1
DB12167LY-30234142Terminated1
DB16216Lazertinib2Active Not Recruiting1
DB16216Lazertinib2Not Yet Recruiting1
DB16216Lazertinib2Recruiting1
DB09078Lenvatinib2Not Yet Recruiting1
DB06599Lexatumumab2Active Not Recruiting1
DB06599Lexatumumab2Recruiting1
DB17107Lifileucel2Recruiting1
DB12130Lorlatinib2Active Not Recruiting1
DB12130Lorlatinib2Recruiting1
DB14123Menthol2Completed1
DB00331Metformin2Terminated1
DB05774Necitumumab2Terminated1
DB09559Necitumumab2Terminated1
DB06192Nimotuzumab2Terminated1
DB09035Nivolumab2Active Not Recruiting3
DB09035Nivolumab2Completed3
DB09035Nivolumab2Recruiting1
DB09035Nivolumab2Terminated2
DB09035Nivolumab2Withdrawn1
DB09074Olaparib2Active Not Recruiting1
DB09074Olaparib2Completed1
DB09330Osimertinib2Active Not Recruiting3
DB09330Osimertinib2Recruiting2
DB01229Paclitaxel2Active Not Recruiting2
DB01229Paclitaxel2Completed1
DB01229Paclitaxel2Not Yet Recruiting1
DB01229Paclitaxel2Recruiting2
DB01229Paclitaxel2Terminated1
DB09037Pembrolizumab2Active Not Recruiting6
DB09037Pembrolizumab2Completed1
DB09037Pembrolizumab2Recruiting4
DB09037Pembrolizumab2Suspended1
DB09037Pembrolizumab2Terminated2
DB09037Pembrolizumab2Unknown Status1
DB00642Pemetrexed2Active Not Recruiting3
DB00642Pemetrexed2Completed4
DB00642Pemetrexed2Not Yet Recruiting1
DB00642Pemetrexed2Recruiting6
DB00642Pemetrexed2Unknown Status2
DB06366Pertuzumab2Completed1
DB12257Platinum2Recruiting1
DB05992Plinabulin2Recruiting1
DB12114Poziotinib2Withdrawn1
DB05578Ramucirumab2Active Not Recruiting2
DB05578Ramucirumab2Completed1
DB05578Ramucirumab2Recruiting1
DB14851Relatlimab2Active Not Recruiting1
DB15766Retifanlimab2Completed1
DB12183Sapitinib2Completed1
DB12048Savolitinib2Completed1
DB11689Selumetinib2Completed1
DB15765Sintilimab2Not Yet Recruiting1
DB15765Sintilimab2Recruiting1
DB15036Sitravatinib2Terminated1
DB09153Sodium chloride2Terminated1
DB15569Sotorasib2Not Yet Recruiting1
DB17286TERT-5722Completed1
DB06584TG40102Completed1
DB00820Tadalafil2Terminated1
DB15133Tepotinib2Not Yet Recruiting1
DB04900Thymalfasin2Withdrawn1
DB14922Tislelizumab2Recruiting1
DB12200Tivantinib2Completed1
DB06273Tocilizumab2Active Not Recruiting1
DB05697Trabedersen2Withdrawn1
DB00072Trastuzumab2Completed1
DB11771Tremelimumab2Active Not Recruiting1
DB15442Trilaciclib2Terminated1
DB17448Tusamitamab ravtansine2Active Not Recruiting1
DB00577Valaciclovir2Completed1
DB05294Vandetanib2Completed1
DB16420Vibostolimab2Active Not Recruiting1
DB00361Vinorelbine2Unknown Status1
DB11925Vistusertib2Completed1
DB15568Adagrasib2 / 3Recruiting1
DB01248Docetaxel2 / 3Terminated1
DB12047Ganetespib2 / 3Terminated1
DB09037Pembrolizumab2 / 3Recruiting2
DB00642Pemetrexed2 / 3Recruiting1
DB00853Temozolomide2 / 3Unknown Status1
DB15568Adagrasib3Active Not Recruiting1
DB00062Albumin human3Active Not Recruiting1
DB00062Albumin human3Recruiting1
DB16087Alflutinib3Recruiting1
DB16640Almonertinib3Recruiting1
DB11595Atezolizumab3Active Not Recruiting1
DB05136Bavituximab3Completed1
DB00112Bevacizumab3Completed1
DB00112Bevacizumab3Terminated1
DB00112Bevacizumab3Unknown Status1
DB00112Bevacizumab3Withdrawn1
DB00958Carboplatin3Active Not Recruiting3
DB00958Carboplatin3Completed1
DB00958Carboplatin3Not Yet Recruiting1
DB00958Carboplatin3Recruiting4
DB00958Carboplatin3Withdrawn1
DB00515Cisplatin3Active Not Recruiting4
DB00515Cisplatin3Not Yet Recruiting1
DB00515Cisplatin3Recruiting3
DB00515Cisplatin3Terminated1
DB16410Datopotamab deruxtecan3Recruiting2
DB01248Docetaxel3Active Not Recruiting3
DB01248Docetaxel3Completed1
DB01248Docetaxel3Terminated1
DB00530Erlotinib3Active Not Recruiting1
DB00099Filgrastim3Active Not Recruiting1
DB00099Filgrastim3Recruiting1
DB12047Ganetespib3Terminated1
DB00317Gefitinib3Active Not Recruiting1
DB00441Gemcitabine3Active Not Recruiting2
DB14740Hyaluronidase3Active Not Recruiting1
DB14740Hyaluronidase3Recruiting1
DB06186Ipilimumab3Active Not Recruiting1
DB09078Lenvatinib3Active Not Recruiting1
DB01043Memantine3Recruiting1
DB09035Nivolumab3Active Not Recruiting1
DB09330Osimertinib3Active Not Recruiting1
DB01229Paclitaxel3Active Not Recruiting3
DB01229Paclitaxel3Completed1
DB01229Paclitaxel3Recruiting3
DB01229Paclitaxel3Withdrawn1
DB09037Pembrolizumab3Active Not Recruiting3
DB09037Pembrolizumab3Not Yet Recruiting2
DB09037Pembrolizumab3Recruiting6
DB00642Pemetrexed3Active Not Recruiting3
DB00642Pemetrexed3Not Yet Recruiting1
DB00642Pemetrexed3Recruiting4
DB00642Pemetrexed3Terminated1
DB12257Platinum3Not Yet Recruiting1
DB12257Platinum3Recruiting1
DB05578Ramucirumab3Active Not Recruiting1
DB12048Savolitinib3Recruiting1
DB17448Tusamitamab ravtansine3Active Not Recruiting1
DB16420Vibostolimab3Active Not Recruiting1
DB11595Atezolizumab4Recruiting1
DB00958Carboplatin4Recruiting1
DB00958Carboplatin4Terminated1
DB00515Cisplatin4Recruiting1
DB11963Dacomitinib4Completed1
DB00530Erlotinib4Suspended1
DB00317Gefitinib4Terminated1
DB00441Gemcitabine4Not Yet Recruiting1
DB00441Gemcitabine4Terminated1
DB09035Nivolumab4Not Yet Recruiting1
DB01229Paclitaxel4Recruiting1
DB09037Pembrolizumab4Recruiting2
DB00642Pemetrexed4Recruiting1
DB00361Vinorelbine4Completed1
DB16695AmivantamabNot AvailableApproved for Marketing1
DB00112BevacizumabNot AvailableNot Yet Recruiting1
DB11791CapmatinibNot AvailableCompleted1
DB16410Datopotamab deruxtecanNot AvailableAvailable1
DB16216LazertinibNot AvailableNot Yet Recruiting1
DB12130LorlatinibNot AvailableCompleted1
DB01229PaclitaxelNot AvailableNot Yet Recruiting1
DB09037PembrolizumabNot AvailableCompleted1
DB09037PembrolizumabNot AvailableRecruiting1
DB12257PlatinumNot AvailableNot Yet Recruiting1
DB00135TyrosineNot AvailableUnknown Status1